Correction to: miR-143 activation regulates smooth muscle and endothelial cell crosstalk in pulmonary arterial hypertension (Circulation Research (2015) 117 (870-883) DOI: 10.1161/CIRCRESAHA.115.306806);MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension

Circulation Research

Volumn 117, Issue 10, 2015, Pages 870-883

  Deng, Lin ^a   Blanco, Francisco J ^a   Stevens, Hannah ^a   Lu, Ruifang ^f   Caudrillier, Axelle ^a   McBride, Martin ^a   McClure, John D ^a   Grant, Jenny ^a   Thomas, Matthew ^b,g   Frid, Maria ^c   Stenmark, Kurt ^c   White, Kevin ^a,b   Seto, Anita G ^d   Morrell, Nicholas W ^e   Bradshaw, Angela C ^a   MacLean, Margaret R ^a   Baker, Andrew H ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d miRagen Therapeutics Inc   (United States)

^e ADDENBROOKE S HOSPITAL   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g ASTRAZENECA R AND D   (Sweden)

Author keywords

cell movement; endothelium; exosomes; hypertension, pulmonary; microRNAs; myocytes, smooth muscle

Indexed keywords

ESTROGEN RECEPTOR; LIVER X RECEPTOR; MICRORNA 143; MICRORNA 143 3P; MICRORNA 143 5P; MICRORNA 145; RETINOID X RECEPTOR; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; MICRORNA; MIRN143 MICRORNA, HUMAN; MIRN143 MICRORNA, MOUSE; MIRN145 MICRORNA, HUMAN; MIRN145 MICRORNA, MOUSE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CALF (BOVINE); CELL MIGRATION; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIUM CELL; EXOSOME; EXPERIMENTAL PULMONARY HYPERTENSION; GENE EXPRESSION; GENE MAPPING; GENE SILENCING; HUMAN; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VIVO STUDY; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PARACRINE SIGNALING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PULMONARY ARTERIAL ENDOTHELIAL CELL; PULMONARY ARTERY SMOOTH MUSCLE CELL; PULMONARY HYPERTENSION; QUANTITATIVE ANALYSIS; RNA ANALYSIS; RNA EXTRACTION; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; ARTERIAL PRESSURE; BINDING SITE; BOVINE; C57BL MOUSE; CASE CONTROL STUDY; CELL COMMUNICATION; CELL MOTION; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE PRESSURE; HELA CELL LINE; HYPERTENSION, PULMONARY; KNOCKOUT MOUSE; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PULMONARY ARTERY; SMOOTH MUSCLE CELL; TIME FACTOR; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE;

ANIMALS; ARTERIAL PRESSURE; BINDING SITES; CASE-CONTROL STUDIES; CATTLE; CELL COMMUNICATION; CELL MOVEMENT; ENDOTHELIAL CELLS; EXOSOMES; FEMALE; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; HYPERTENSION, PULMONARY; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROMOTER REGIONS, GENETIC; PULMONARY ARTERY; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSFECTION; VASCULAR REMODELING; VENTRICULAR FUNCTION, RIGHT; VENTRICULAR PRESSURE;

EID: 84944887229     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/RES.0000000000000136     Document Type: Erratum

References (43)

1. Thenappan T, Ryan JJ, Archer SL. Evolving epidemiology of pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012;186:707-709. doi: 10.1164/rccm.201207-1266ED.
2. Tuder RM, Abman SH, Braun T, Capron F, Stevens T, Thistlethwaite PA, Haworth SG. Development and pathology of pulmonary hypertension. J Am Coll Cardiol. 2009;54:S3-S9. doi: 10.1016/j.jacc.2009.04.009.
3. Morrell NW, Adnot S, Archer SL, Dupuis J, Jones PL, MacLean MR, McMurtry IF, Stenmark KR, Thistlethwaite PA, Weissmann N, Yuan JX, Weir EK. Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54:S20-S31. doi: 10.1016/j.jacc.2009.04.018.
4. Austin ED, Lahm T, West J, Tofovic SP, Johansen AK, Maclean MR, Alzoubi A, Oka M. Gender, sex hormones and pulmonary hypertension. Pulm Circ. 2013;3:294-314. doi: 10.4103/2045-8932.114756.
5. Upton PD, Davies RJ, Tajsic T, Morrell NW. Transforming growth factor-?(1) represses bone morphogenetic protein-mediated Smad signaling in pulmonary artery smooth muscle cells via Smad3. Am J Respir Cell Mol Biol. 2013;49:1135-1145. doi: 10.1165/rcmb.2012-0470OC.
6. Liu D, Morrell NW. Genetics and the molecular pathogenesis of pulmonary arterial hypertension. Curr Hypertens Rep. 2013;15:632-637. doi: 10.1007/s11906-013-0393-9.
7. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281-297.
8. Saini HK, Griffiths-Jones S, Enright AJ. Genomic analysis of human microRNA transcripts. Proc Natl Acad Sci USA. 2007;104:17719-17724. doi: 10.1073/pnas.0703890104.
9. Chien CH, Sun YM, Chang WC, Chiang-Hsieh PY, Lee TY, Tsai WC, Horng JT, Tsou AP, Huang HD. Identifying transcriptional start sites of human microRNAs based on high-throughput sequencing data. Nucleic Acids Res. 2011;39:9345-9356. doi: 10.1093/nar/gkr604.
10. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN, Srivastava D. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature. 2009;460:705-710. doi: 10.1038/nature08195.
11. Boettger T, Beetz N, Kostin S, Schneider J, Krüger M, Hein L, Braun T. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest. 2009;119:2634-2647. doi: 10.1172/JCI38864.
12. Elia L, Quintavalle M, Zhang J, Contu R, Cossu L, Latronico MV, Peterson KL, Indolfi C, Catalucci D, Chen J, Courtneidge SA, Condorelli G. The knockout of miR-143 and-145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ. 2009;16:1590-1598. doi: 10.1038/cdd.2009.153.
13. Lovren F, Pan Y, Quan A, Singh KK, Shukla PC, Gupta N, Steer BM, Ingram AJ, Gupta M, Al-Omran M, Teoh H, Marsden PA, Verma S. MicroRNA-145 targeted therapy reduces atherosclerosis. Circulation. 2012;126:S81-S90. doi: 10.1161/CIRCULATIONAHA.111.084186.
14. Hutcheson R, Terry R, Chaplin J, Smith E, Musiyenko A, Russell JC, Lincoln T, Rocic P. MicroRNA-145 restores contractile vascular smooth muscle phenotype and coronary collateral growth in the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2013;33:727-736. doi: 10.1161/ATVBAHA.112.301116.
15. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Röxe T, Müller-Ardogan M, Bonauer A, Zeiher AM, Dimmeler S. Circulating microRNAs in patients with coronary artery disease. Circ Res. 2010;107:677-684. doi: 10.1161/CIRCRESAHA.109.215566.
16. Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu Q, Deitch EA, Huo Y, Delphin ES, Zhang C. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res. 2009;105:158-166. doi: 10.1161/CIRCRESAHA.109.197517.
17. Caruso P, Dempsie Y, Stevens HC, et al. A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples. Circ Res. 2012;111:290-300. doi: 10.1161/CIRCRESAHA.112.267591.
18. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654-659. doi: 10.1038/ncb1596.
19. Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009;9:581-593. doi: 10.1038/nri2567.
20. Hergenreider E, Heydt S, Tréguer K, Boettger T, Horrevoets AJ, Zeiher AM, Scheffer MP, Frangakis AS, Yin X, Mayr M, Braun T, Urbich C, Boon RA, Dimmeler S. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol. 2012;14:249-256. doi: 10.1038/ncb2441.
21. Loyer X, Vion AC, Tedgui A, Boulanger CM. Microvesicles as cell-cell messengers in cardiovascular diseases. Circ Res. 2014;114:345-353. doi: 10.1161/CIRCRESAHA.113.300858.
22. Garrido-Martín EM, Blanco FJ, Roquè M, Novensà L, Tarocchi M, Lang UE, Suzuki T, Friedman SL, Botella LM, Bernabeú C. Vascular injury triggers Krüppel-like factor 6 mobilization and cooperation with specificity protein 1 to promote endothelial activation through upregulation of the activin receptor-like kinase 1 gene. Circ Res. 2013;112:113-127. doi: 10.1161/CIRCRESAHA.112.275586.
23. Yang J, Li X, Li Y, Southwood M, Ye L, Long L, Al-Lamki RS, Morrell NW. Id proteins are critical downstream effectors of BMP signaling in human pulmonary arterial smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2013;305:L312-L321. doi: 10.1152/ajplung.00054.2013.
24. White K, Johansen AK, Nilsen M, Ciuclan L, Wallace E, Paton L, Campbell A, Morecroft I, Loughlin L, McClure JD, Thomas M, Mair KM, MacLean MR. Activity of the estrogen-metabolizing enzyme cytochrome P450 1B1 influences the development of pulmonary arterial hypertension. Circulation. 2012;126:1087-1098. doi: 10.1161/CIRCULATIONAHA.111.062927.
25. Lefebvre P, Benomar Y, Staels B. Retinoid X receptors: common heterodimerization partners with distinct functions. Trends Endocrinol Metab. 2010;21:676-683. doi: 10.1016/j.tem.2010.06.009.
26. Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang HM, Marth GT, McVean GA; 1000 Genomes Project Consortium. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491:56-65. doi: 10.1038/nature11632.
27. Shimbo K, Miyaki S, Ishitobi H, Kato Y, Kubo T, Shimose S, Ochi M. Exosome-formed synthetic microRNA-143 is transferred to osteosarcoma cells and inhibits their migration. Biochem Biophys Res Commun. 2014;445:381-387. doi: 10.1016/j.bbrc.2014.02.007.
28. Jordan SD, Krüger M, Willmes DM, Redemann N, Wunderlich FT, Brönneke HS, Merkwirth C, Kashkar H, Olkkonen VM, Böttger T, Braun T, Seibler J, Brüning JC. Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat Cell Biol. 2011;13:434-446. doi: 10.1038/ncb2211.
29. Xin M, Small EM, Sutherland LB, Qi X, McAnally J, Plato CF, Richardson JA, Bassel-Duby R, Olson EN. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev. 2009;23:2166-2178. doi: 10.1101/gad.1842409.
30. Mair KM, Johansen AK, Wright AF, Wallace E, MacLean MR. Pulmonary arterial hypertension: basis of sex differences in incidence and treatment response. Br J Pharmacol. 2014;171:567-579. doi: 10.1111/bph.12281.
31. Valbuena-Diez AC, Blanco FJ, Oujo B, Langa C, Gonzalez-Nuñez M, Llano E, Pendas AM, Diáz M, Castrillo A, Lopez-Novoa JM, Bernabeu C. Oxysterol-induced soluble endoglin release and its involvement in hypertension. Circulation. 2012;126:2612-2624. doi: 10.1161/CIRCULATIONAHA.112.101261.
32. Choudhry H, Schödel J, Oikonomopoulos S, Camps C, Grampp S, Harris AL, Ratcliffe PJ, Ragoussis J, Mole DR. Extensive regulation of the non-coding transcriptome by hypoxia: role of HIF in releasing paused RNApol2. EMBO Rep. 2014;15:70-76. doi: 10.1002/embr.201337642.
33. Zuo L, Rose BA, Roberts WJ, He F, Banes-Berceli AK. Molecular characterization of reactive oxygen species in systemic and pulmonary hypertension. Am J Hypertens. 2014;27:643-650. doi: 10.1093/ajh/hpt292.
34. Mayorga ME, Penn MS. miR-145 is differentially regulated by TGF-?1 and ischaemia and targets Disabled-2 expression and wnt/?-catenin activity. J Cell Mol Med. 2012;16:1106-1113. doi: 10.1111/j.1582-4934.2011.01385.x.
35. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O, Voelkel NF, Rabinovitch M. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43:13S-24S. doi: 10.1016/j.jacc.2004.02.029.
36. Archer SL, Weir EK, Wilkins MR. Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies. Circulation. 2010;121:2045-2066. doi: 10.1161/CIRCULATIONAHA.108.847707.
37. Grant JS, White K, MacLean MR, Baker AH. MicroRNAs in pulmonary arterial remodeling. Cell Mol Life Sci. 2013;70:4479-4494. doi: 10.1007/s00018-013-1382-5.
38. Tréguer K, Heinrich EM, Ohtani K, Bonauer A, Dimmeler S. Role of the microRNA-17-92 cluster in the endothelial differentiation of stem cells. J Vasc Res. 2012;49:447-460. doi: 10.1159/000339429.
39. Ma Q, Jiang Q, Pu Q, Zhang X, Yang W, Wang Y, Ye S, Wu S, Zhong G, Ren J, Zhang Y, Liu L, Zhu W. MicroRNA-143 inhibits migration and invasion of human non-small-cell lung cancer and its relative mechanism. Int J Biol Sci. 2013;9:680-692. doi: 10.7150/ijbs.6623.
40. Xu B, Niu X, Zhang X, Tao J, Wu D, Wang Z, Li P, Zhang W, Wu H, Feng N, Wang Z, Hua L, Wang X. miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS. Mol Cell Biochem. 2011;350:207-213. doi: 10.1007/s11010-010-0700-6.
41. Wang L, Xiong H, Wu F, Zhang Y, Wang J, Zhao L, Guo X, Chang LJ, Zhang Y, You MJ, Koochekpour S, Saleem M, Huang H, Lu J, Deng Y. Hexokinase 2-mediated Warburg effect is required for PTEN-and p53-deficiency-driven prostate cancer growth. Cell Rep. 2014;8:1461-1474. doi: 10.1016/j.celrep.2014.07.053.
42. Bang C, Batkai S, Dangwal S, et al. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Invest. 2014;124:2136-2146. doi: 10.1172/JCI70577.
43. Sahoo S, Losordo DW. Exosomes and cardiac repair after myocardial infarction. Circ Res. 2014;114:333-344. doi: 10.1161/CIRCRESAHA. 114.300639.